Lijun Sun

机构：University of Kentucky · ORCID：0000-0002-8380-1721

发表论文 82 篇 · 总被引 28795 次 · h-index 35

代表论文

• Tumor-targeted delivery of a STING agonist improves cancer immunotherapy (2022 · Proceedings of the National Academy of Sciences · 被引 202)
• The STING agonist IMSA101 enhances chimeric antigen receptor T cell function by inducing IL-18 secretion (2024 · Nature Communications · 被引 56)
• Phase 1 first-in-human dose-escalation study of IMSA101, a novel cyclic di-nucleotide STING agonist, for patients with advanced solid tumor malignancies (2025 · Journal for ImmunoTherapy of Cancer · 被引 23)
• Cardiac Injury Regulates Neuroinflammation Through Extracellular Vesicle–Mediated Heart-Brain Crosstalk (2025 · JACC Basic to Translational Science · 被引 16)
• The prognostic value of TCF1+CD8+T in primary small cell carcinoma of the esophagus (2021 · Cancer Science · 被引 16)
• Lipopolysaccharide reduces melanin synthesis in vitiligo melanocytes by regulating autophagy (2022 · Experimental Dermatology · 被引 13)